Thank you, Jay, and thanks, everyone, for joining us today. In the next few minutes, I'll provide certain details of our financial performance in the 2023 second quarter, but I would encourage you to review our latest Form 10-Q, which we filed earlier as it contains far more information about our business operations and financial performance than we will cover on this call. Before I begin our financial review, I'd like to take a minute to again highlight the new chart we added to our press release last quarter and which we will include each quarter going forward. It provides 10 quarters of LTM over the last 12 months, historical data for four key metrics: sales, gross profit dollars, gross margin percent and EBITDA. As we have pointed out in the past, we believe that our individual quarters can be affected by outside factors. These might include timing fluctuations, customer shipments and supply chain issues. Any of these during a given reporting cycle could temporarily disrupt our momentum. Consequently, we believe it is more appropriate to review our business on a longer-term 12-month basis rather than a strict calendar year. This approach will help normalize these potential anomalies and offer a better gauge of our company's long-term success. So switching to our second quarter financial performance. As Jay noted, we made progress in several key performance areas with quarterly revenue up nearly 8% from the prior year period. Again, we're particularly pleased by this revenue momentum as this quarter's year-over-year growth continues to come on a strong prior year comparable. We also saw sustained year-over-year backlog levels, increases in the year-over-year gross margin and solid levels of net income and EBITDA. Over the past several quarters, we have taken necessary steps to create a firm financial platform that can be flexible and respond quickly to changing macroeconomic conditions. While we are constantly vigilant to the negative impacts of inflation, we are encouraged as our customers are reporting fewer supply chain disruptions, and we are more optimistic given the continued sales momentum we saw in the second quarter. Evidence of this renewed sense of optimism can be found in our total backlog level last quarter and our new record level of bookings. Total backlog continues to exceed $100 million. Coupled with the strong bookings levels and our solid foundation, we are confident that we can maintain momentum into the second half of the year. Increased shipments during the quarter resulted in orders moving through the pipeline quicker and causing backlog levels to start reaching a steady state. In the near term, we expect backlog levels to remain relatively constant with future growth coming from accelerated contributions from both new and existing customers as well as technology innovations. In the balance of my comments, I'll review key areas which drove our second quarter financial performance. They include: First, a review of certain factors impacting our income statement; second, selected items, which influenced Nortech's cash flow statement; and lastly, a brief review of the balance sheet. As usual, if you have specific questions about these items or any of our quarterly financial results, I'll be happy to address them during the Q&A portion of this afternoon's call. In Q2 2023, near record revenue totaled $35 million. This represents a $7.7 million increase from revenue of $32.5 million in the second quarter of 2022 and was up slightly from the prior quarter, which increased with increases coming from higher volume and previous pricing actions. Again, this performance was particularly noteworthy as it compares to a strong performance in the prior year period. In fact, we've been able to sustain revenue growth over the trailing 12-month period despite the stronger historical comparables. Nortech second quarter 2023 revenue performance was driven by growth in our medical as well as our aerospace and defense categories. In the second quarter, the medical market was up $2.1 million or 11.2% as compared to 2022 with the majority of the increase caring for medical component products. In the second quarter, revenue from the aerospace and events market was up $829,000 or 18% from the prior year. Included in the financial performance for the current year, gross profit totaled $5.5 million or 15.6% compared to gross profit of $5 million or 15.4% in the prior year quarter. Second quarter 2023 operating expenses totaled $4.4 million, a 10% increase from the second quarter of 2022 operating expenses of $4 million and flat on a sequential basis. The $396,000 increase in year-over-year operating expenses, driven primarily by a $437,000 increase in second quarter general and administrative expenses from the prior year quarter. The majority of the increase in year-over-year G&A costs were due to higher professional fees and increased labor costs. Finally, we had a reduction of $34,000 in the year-over-year research and development costs. We believe that this level of investment was sufficient to support new technologies such as the AOX scalable platform and the Flex Faraday Xtreme technology. As a result of our performance in the second quarter of 2023, net income totaled $635,000 or $0.22 per diluted share, in line with the prior quarter and second quarter of 2022. Through the first half of 2023, net income totaled $1.3 million versus $857,000 in the prior year first half. Also, all employee retention credits or ERC, have been received as of June 30, 2023, and our balance sheet and cash flow statements reflect that. Next, in the second quarter of 2023, net cash used by operating activities was $1.4 million. Receivables at June 30, 2023 were $17.4 million, up from receivables of $16.2 million in the prior quarter and $16 million at year-end. This is in line with the seasonal pattern that we've seen evolve over the past couple of years. The first half of the year has been typically marked by higher receivable levels while cash collections accelerated during the summer months and second half receivable levels declined. During the second quarter, increased shipments as well as less pressure to respond to global supply chain shortages, capital inventory levels at $21.1 million, relatively flat to quarter levels and down from $22.4 million at December 31, 2022. We ended the second quarter of 2023 with a $5.3 million of borrowing capacity on our $16 million line of credit for Bank of America. This credit agreement is important in giving Nortech the flexibility to manage through the headwinds we have experienced in the last few years and the previously mentioned seasonal fluctuations we see in our receivables balances and collections. At June 30, 2023, cash and equivalents totaled $1.9 million, down from $2.5 million at the end of the prior year. However, we believe that our existing financing arrangements, anticipated cash flows from operations and cash on hand will be sufficient to satisfy our working capital needs in 2023 as well as any capital expenditures and debt repayments. We are confident that we have created a solid financial base to take this company into the future. On a final note, let me reiterate that our top financial priorities for 2023 remain unchanged. First, we are extremely focused on continuing to strengthen our balance sheet and mitigate impacts we may see from changes in the economic environment or seasonality. Now, we will take further advantage of opportunities to align our operations and infrastructure with the market demand that we are seeing in order to deliver sustainable free cash flow growth. Our confidence in results from the growth momentum we saw in 2022 that has sustained thus far in 2023. Coupled with disciplined lean operation execution and R&D innovation, we believe Nortech can deliver on our objectives. With that, I'll turn the back over to Jay for closing comments.